In this edition of Null and Noteworthy, tests of intranasal oxytocin and an Angelman syndrome treatment fail to see results.

An autism brain imaging study published seven years ago received an expression of concern last month after its authors failed to uphold a promise to make their raw data freely available.

Conflicts of interest and methodological issues sully a study published 18 July in the Journal of Autism and Developmental Disorders, autism researchers say.

In this edition of Null and Noteworthy, researchers open the case on acetaminophen and close it on oxytocin.

After a study revised a popular measure for alexithymia, it was pulled for copyright infringement because the authors did not pay a $40 fee or obtain permission to use the measure.

An expanding collection of websites compiles up-to-date information on the characteristics of people with mutations in genes linked to autism and other conditions.